跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMDELLTRA tarlatamab 10 mg powder for injection vial with intravenous (IV) solution stabiliser vial composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
IMDELLTRA tarlatamab 10 mg powder for injection vial with intravenous (IV) solution stabiliser vial composite pack
Approved
STANDARD
IMDELLTRA tarlatamab 10 mg powder for injection vial with intravenous (IV) solution stabiliser vial composite pack
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Jul 1, 2025
Approval ID
94b613e3296aa929
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
94b613e3296aa929
Product Name
IMDELLTRA tarlatamab 10 mg powder for injection vial with intravenous (IV) solution stabiliser vial composite pack
Artg Id
453166
Artg Name
IMDELLTRA tarlatamab 10 mg powder for injection vial with intravenous (IV) solution stabiliser vial composite pack
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2025-06-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
REP
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Jul 1, 2025
Approval ID
94b613e3296aa929
Type
Standard
Back to TGA Approvals